Rasagiline

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 774 publications

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Journal: Journal of neurology

Published: March 23, 2026

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Journal: American journal of ophthalmology

Published: March 10, 2026

Fatigue in Parkinson's disease and management with NIBS.

Fatigue in Parkinson's disease and management with NIBS.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 12, 2026

Power and sample size calculation of two-sample projection-based testing for sparsely observed functional data.

Power and sample size calculation of two-sample projection-based testing for sparsely observed functional data.

Journal: Stat

Published: January 15, 2026

Discovery of novel N-(prop-2-yn-1-yl)-1,2,3,4-tetrahydronaphthalen-1-amine derivatives as MAO-B inhibitors for the treatment of Parkinson's disease.

Discovery of novel N-(prop-2-yn-1-yl)-1,2,3,4-tetrahydronaphthalen-1-amine derivatives as MAO-B inhibitors for the treatment of Parkinson's disease.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 08, 2026

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Pharmacokinetics and pharmacodynamics of anti-Parkinson drugs in geriatric patients : Key for optimization of treatment

Journal: Zeitschrift fur Gerontologie und Geriatrie

Published: December 19, 2025

Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factors.

Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson's disease patients: the role of clinical and demographic factors.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: December 15, 2025

Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents.

Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents.

Journal: ChemMedChem

Published: December 15, 2025

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.

Journal: Frontiers in neuroscience

Published: December 01, 2025

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Journal: Frontiers in neurology

Published: November 24, 2025

Consensus Molecules Associated with Parkinson's Disease.

Consensus Molecules Associated with Parkinson's Disease.

Journal: Neurology international

Published: November 20, 2025

Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis.

Effects of MAO-B and COMT inhibitors on sleep disturbances in Parkinson's disease: A network meta-analysis.

Journal: Journal of movement disorders

Published: September 19, 2025

Showing 1-12 of 774

Last Updated: 06/30/2026